T

The Rogosin Institute | East Side Dialysis

Research site

(Unclaimed)

Location

504-506 East 74th Street #403, New York, New York, United States of America

Site insights

Top conditions

Top treatments

Tolvaptan

Bortezomib

CTP-499

Velcade®

Tacrolimus

metoprolol

Povetacicept

Aliskiren

iPTH

Velcade

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 26 total trials

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserv...

Enrolling

Immunoglobulin A Nephropathy

Drug: Placebo (matched to Povetacicept)

Drug: Povetacicept

Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis

Dialysis-related amyloidosis (DRA) is a serious complication of long-term hemodialysis (HD). Its pathogenic mechanism involves accumulation of β2-mic...

Enrolling

Dialysis Amyloidosis

Device: Lixelle® treatment